Amgen Inc. buy marge
Start price
21.06.15
/
50%
€141.91
Target price
24.05.16
€160.00
Performance (%)
-3.29%
End price
24.05.16
€134.02
Summary
This prediction ended on 24.05.16 with a price of €134.02. With a performance of -3.29%, the BUY prediction by marge finished with a loss. marge has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Amgen Inc. | 0.754% | 0.754% | 11.025% | 47.066% |
| iShares Core DAX® | -1,10 % | -6,08 % | 3,20 % | 53,31 % |
| iShares Nasdaq 100 | 0,33 % | 2,33 % | 20,24 % | 93,48 % |
| iShares Nikkei 225® | -1,08 % | -7,99 % | 27,55 % | 52,32 % |
| iShares S&P 500 | -0,06 % | 0,88 % | 14,89 % | 66,74 % |
Comments by marge for this prediction
In the thread Amgen Inc. diskutieren
Amgen
Aus meinem Langfristportofolio mit den Large-cap biotechs:
1.Gilead Science (40%)
2. Amgen (15%)
3. Celgene (25%),
und den smaller-cap biotechs:
Isis Pharmaceuticals, ChemoCentryx, Acceleron,
Portola Pharmaceuticals, Cempra, Supernus mit anteiliger Gesamtgewichtung von 20%
Nachfragen zu den einzelnen Werten beantworte ich gerne.
(Laufzeit überschritten)